Experiment description | Enriched miRNAs | Number of reported genes | Reference |
---|---|---|---|
HeLa cells transfected with miR-1 | miR-1 | 96 repressed genes | [35] |
HeLa cells transfected with miR-124 | miR-124 | 174 repressed genes | [35] |
HeLa cells transfected with miR-373 | miR-373 | 65 repressed genes | [35] |
LNCaP cells treatedwith pre-miR-1 | miR-1 | 88 repressed genes and 80 upregulated genes | [36] |
LNCaP cells treatedwith pre-miR-206 | miR-206 | 83 repressed genes and 62 upregulated genes | [36] |
LNCaP cells treatedwith pre-miR-27b | miR-27b | 51 repressed genes and 157 upregulated genes | [36] |
LNCaP cells transfected with pre-miR-32 | miR-32 | 67 repressed genes | [37] |
LNCaP cells transfected with pre-miR-148a | miR-148a | 79 repressed genes | [37] |
Genes predicted to be targets of 11 prostate miRNAs extracted from PRedNet | miR(1, 204, 205, 143, 145, 221, 222, 27b, 133b, 31, let-7 | 1854 | |
Altered genes in prostate cancer using Taylor data | Â | 480 downregulated in prostate and 51 upregulated in prostate 269 downregulated genes in PCa samples that have BCR recurrence | [39] |
Genes associated with BCR event in prostate cancer | Â | Â | [39] |